Specialized Solid Form Screening Techniques

被引:107
作者
Newman, Ann [1 ]
机构
[1] Seventh St Dev Grp, Indiana, PA 47902 USA
关键词
MEDIATED PHASE-TRANSFORMATION; STABLE POLYMORPH; PHARMACEUTICAL COCRYSTALS; CRYSTAL-GROWTH; CRYSTALLIZATION; SOLUBILITY; STATE; CLASSIFICATION; CARBAMAZEPINE; SYSTEMS;
D O I
10.1021/op300241f
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Solid form screening is an integral part of many development plans at various companies and includes polymorph, salt, cocrystal, amorphous, and amorphous dispersion screens. There are a number of traditional solvent- and nonsolvent-based methods that are employed for these screens. Over time, specialized screens have been developed to deal with difficult molecules and situations or to push the limits of traditional experiments. This contribution outlines a variety of specialized screening approaches for polymorphs, salts, cocrystals, and amorphous dispersions. Many techniques are amenable to laboratory equipment and can be incorporated with minimal start-up time, while others are very specific and will need specialized equipment and/or expertise.
引用
收藏
页码:457 / 471
页数:15
相关论文
共 96 条
[1]   Solid form screening - A review [J].
Aaltonen, Jaakko ;
Alleso, Morten ;
Mirza, Sabiruddin ;
Koradia, Vishal ;
Gordon, Keith C. ;
Rantanen, Jukka .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (01) :23-37
[2]  
Abromov Y. A., 2010, CHEM ENG PHARM IND R, P491
[3]   Towards Effective Solid Form Screening [J].
Alleso, Morten ;
Tian, Fang ;
Cornett, Claus ;
Rantanen, Jukka .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (09) :3711-3718
[4]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[5]   Application of Ionic Liquid to Polymorphic Design of Pharmaceutical Ingredients [J].
An, Ji-Hun ;
Kim, Jong-Min ;
Chang, Sang-Mok ;
Kim, Woo-Sik .
CRYSTAL GROWTH & DESIGN, 2010, 10 (07) :3044-3050
[6]  
[Anonymous], 2005, JANUS HEAD, V8.1, p[254, 260]
[7]   Towards crystal structure prediction of complex organic compounds - a report on the fifth blind test [J].
Bardwell, David A. ;
Adjiman, Claire S. ;
Arnautova, Yelena A. ;
Bartashevich, Ekaterina ;
Boerrigter, Stephan X. M. ;
Braun, Doris E. ;
Cruz-Cabeza, Aurora J. ;
Day, Graeme M. ;
Della Valle, Raffaele G. ;
Desiraju, Gautam R. ;
van Eijck, Bouke P. ;
Facelli, Julio C. ;
Ferraro, Marta B. ;
Grillo, Damian ;
Habgood, Matthew ;
Hofmann, Detlef W. M. ;
Hofmann, Fridolin ;
Jose, K. V. Jovan ;
Karamertzanis, Panagiotis G. ;
Kazantsev, Andrei V. ;
Kendrick, John ;
Kuleshova, Liudmila N. ;
Leusen, Frank J. J. ;
Maleev, Andrey V. ;
Misquitta, Alston J. ;
Mohamed, Sharmarke ;
Needs, Richard J. ;
Neumann, Marcus A. ;
Nikylov, Denis ;
Orendt, Anita M. ;
Pal, Rumpa ;
Pantelides, Constantinos C. ;
Pickard, Chris J. ;
Price, Louise S. ;
Price, Sarah L. ;
Scheraga, Harold A. ;
van de Streek, Jacco ;
Thakur, Tejender S. ;
Tiwari, Siddharth ;
Venuti, Elisabetta ;
Zhitkov, Ilia K. .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2011, 67 :535-551
[8]   Ritonavir: An extraordinary example of conformational polymorphism [J].
Bauer, J ;
Spanton, S ;
Henry, R ;
Quick, J ;
Dziki, W ;
Porter, W ;
Morris, J .
PHARMACEUTICAL RESEARCH, 2001, 18 (06) :859-866
[9]   Crystallisation of the stable polymorph of hydroxytriendione: Seeding process and effects of purity [J].
Beckmann, W ;
Otto, W ;
Budde, U .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2001, 5 (04) :387-392
[10]   PHARMACEUTICAL SALTS [J].
BERGE, SM ;
BIGHLEY, LD ;
MONKHOUSE, DC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (01) :1-19